These final results, together with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the principle of targeting ACKR3 as a novel solution to modulate the opioid technique, which could open new therapeutic avenues for opioid-related disorders. So, before investing in this https://brennusk504imm1.blogdemls.com/profile